alto.comHealthcare / Digital HealthFounded: 2015Funding to Date: $1.24B
Alto Pharmacy is a digital pharmacy focused on delivering prescriptions to patients without delivery fees. As with physical pharmacies, patients are able to chat directly with Alto pharmacists to ask questions about their care across general health, sexual health, heart health, fertility, and more. Alto Pharmacy was founded in 2015 by Jamie Karraker, Mattieu Gamache-Asselin, and Vladimir Blumen and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/25/2023 | Series EE-1 | $2.44MM | $xx.xx | $798.78MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
143,458
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/25/2023 | Series CC-4 | $6.3MM | $xx.xx | $798.78MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,388,698
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/25/2023 | Series F | $111.26MM | $xx.xx | $798.78MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
18,110,665
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/27/2022 | Series EE | $185.52MM | $xx.xx | $1.51B | Softbank | |
Price per Share
$xx.xx
Shares Outstanding
12,000,128
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Softbank
|
||||||
02/04/2020 | Series DD | $246.4MM | $xx.xx | $751.58MM | Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Softbank, Zola Global | |
Price per Share
$xx.xx
Shares Outstanding
25,130,023
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Softbank, Zola Global
|
||||||
06/19/2019 | Series CC | $30MM | $xx.xx | $261.15MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,830,751
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/05/2018 | Series CC-3 | $33,998.24 | $xx.xx | $164.84MM | Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital | |
Price per Share
$xx.xx
Shares Outstanding
12,883
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital
|
||||||
12/05/2018 | Series CC-2 | $9.38MM | $xx.xx | $164.84MM | Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital | |
Price per Share
$xx.xx
Shares Outstanding
2,316,805
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital
|
||||||
12/05/2018 | Series CC-1 | $41.03MM | $xx.xx | $164.84MM | Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital | |
Price per Share
$xx.xx
Shares Outstanding
8,616,165
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Capital
|
||||||
06/12/2017 | Series BB | $17.15MM | $xx.xx | $55.98MM | Craig Sherman, Daniel Kan, Greenoaks Capital, Jackson Square Ventures, Justin Kan, Rahul Mehta | |
Price per Share
$xx.xx
Shares Outstanding
5,902,610
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Craig Sherman, Daniel Kan, Greenoaks Capital, Jackson Square Ventures, Justin Kan, Rahul Mehta
|
||||||
06/10/2016 | Series AA-1 | $649,991.76 | $xx.xx | $17.25MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
774,722
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
06/10/2016 | Series AA | $5.95MM | $xx.xx | $17.25MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,879,912
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|